Replies to post #22256 on The Rising Influence of Rising Affluence

[DewDiligence]

PFE invests in China’s CStone—grabs PD-L1 commercialization rights in mainland China:

https://endpts.com/pfizer-infuses-200m-into-cstone-scoring-a-second-pd-l1-and-outlining-a-sprawling-china-pact/